NOBIPOL: The Norwegian Biopolymer Laboratory
|Center for Biopolymer Engineering at NTNU||
NOBIPOL is a multidisciplinary research group within NTNU devoted to the field Biopolymer Engineering, with main focus on the science and technologies of marine polysaccharides, in particular alginates and chitosans.
On the basis of more than 50 years of contineous research in the field NOBIPOL posesses unmatched competence and experience in all aspects of science and technology of marine polysaccharides.
The current activities of NOBIPOL take place within the Department of Biotechnology, in close collaboration with the Department of Physics, the Department of Cancer Research and Molecular Medicine, as well as SINTEF Materials and Chemistry.
Professors Olav Smidsrød and Terje Espevik, are both on the prestigeous list of Highly Cited Researchers (ISI Web of Knowledge).
Carrageenans and agar
Chitosan-based nanoparticles for non-viral gene delivery
2010: The Concordix soft-gel technology developed in collaboration with NOBIPOL is commercialised by Ayanda.
2009-2012: Several patent applications filed throgh NTNU Technology Transfer office
2006: Two novel companies (start-ups) based on NOBIPOL research: Vireo AS (Sphagnan technology) and AlgiPharma AS (alginate technologies for cystic fibrosis and wound healing).
2006: Chitosan oligomers for gene delivery developed by NOBIPOL commercialised by FMC NovaMatrix
2006: Cosmetic product based on marine collagen developed by NOBIPOL commercialised by Kilda Biolink ASA
2006: Alginate based fish feed product for immune stimulation based on NOBIPOL research commercialised by BioMar
Editor: Bjørn E. Christensen, Contact address : B.Christensen@biotech.ntnu.no, Updated: 28.01.2013